FACTOR VII DEFICIENCY

Clinical trials for FACTOR VII DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new FACTOR VII DEFICIENCY trials appear

Sign up with your email to follow new studies for FACTOR VII DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New injection aims to curb bleeding in rare clotting disorder

Disease control Not yet recruiting

This phase II trial tests an injected drug called SR604 in people with congenital Factor VII deficiency, a rare bleeding disorder. The goal is to see if SR604 can reduce the number of bleeding episodes and improve safety. The study includes 12 participants aged 12 to 65 who have …

Matched conditions: FACTOR VII DEFICIENCY

Phase: PHASE2 • Sponsor: Shanghai RAAS Blood Products Co., Ltd. • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

FACTOR VII DEFICIENCY

Get alerted when new FACTOR VII DEFICIENCY trials appear

New injection aims to curb bleeding in rare clotting disorder